• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二肽基肽酶-4 是糖尿病肾病的潜在分子生物标志物。

Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease.

机构信息

The Second Hospital of Shandong University, Ji'nan, Shandong, People's Republic of China.

出版信息

Diab Vasc Dis Res. 2012 Oct;9(4):301-8. doi: 10.1177/1479164111434318. Epub 2012 Mar 2.

DOI:10.1177/1479164111434318
PMID:22388283
Abstract

The present study was designed to identify the changes in microvesicle-dipeptidyl peptidase-IV (DPP IV) levels in human urine and serum, and to determine whether there were correlations with the severity of diabetic kidney disease (DKD). A total of 127 patients with type 2 diabetes mellitus (T2DM) were divided into three groups according to the urinary albumin/ creatinine ratio (UACR): microalbuminuria group (n = 50); macroalbuminuria group (n = 34) and normoalbuminuria group (n = 43), and 34 age- and sex-matched non-diabetic healthy subjects were selected as controls. Microvesicle-bound DPP IV and free urinary DPP IV were separated by a filtra-centrifugation method. The total microvesicles were captured by a specific monoclonal antibody, AD-1. DPP IV activity was determined by measuring the cleavage of chromogenic free 4-nitroaniline from Gly-Pro-p-nitroanilide at 405 nm with an ELISA plate reader. DPP IV protein levels were determined by ELISA and Western blot. Our results showed that the microvesicle-bound type was the major form of DPP IV in urine; the urinary microvesicle-DPP IV excretion of each T2DM group was significantly higher compared with controls. The urinary microvesicle-DPP IV level was positively correlated with UACR in patients with T2DM. These findings suggest that the urinary level of microvesicle-bound DPP IV is associated with the severity of DKD.

摘要

本研究旨在鉴定人尿液和血清中小微囊泡二肽基肽酶-IV(DPP IV)水平的变化,并确定其与糖尿病肾病(DKD)严重程度的相关性。共纳入 127 例 2 型糖尿病患者(T2DM),根据尿白蛋白/肌酐比值(UACR)分为三组:微量白蛋白尿组(n = 50);大量白蛋白尿组(n = 34)和正常白蛋白尿组(n = 43),并选择 34 例年龄和性别匹配的非糖尿病健康受试者作为对照。采用超滤离心法分离微囊泡结合型 DPP IV 和游离型尿 DPP IV。用特异性单克隆抗体 AD-1 捕获总微囊泡。用酶联免疫吸附试验(ELISA)板阅读器测定色原性游离 4-硝基苯胺从 Gly-Pro-p-硝基苯胺的裂解,以测定 DPP IV 活性。用 ELISA 和 Western blot 法测定 DPP IV 蛋白水平。我们的结果表明,微囊泡结合型是尿中 DPP IV 的主要形式;各 T2DM 组的尿微囊泡-DPP IV 排泄量均明显高于对照组。T2DM 患者的尿微囊泡-DPP IV 水平与 UACR 呈正相关。这些发现表明,尿中小微囊泡结合型 DPP IV 的水平与 DKD 的严重程度相关。

相似文献

1
Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease.二肽基肽酶-4 是糖尿病肾病的潜在分子生物标志物。
Diab Vasc Dis Res. 2012 Oct;9(4):301-8. doi: 10.1177/1479164111434318. Epub 2012 Mar 2.
2
Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease.尿微泡结合的尿调节蛋白:糖尿病肾病的一种潜在分子生物标志物。
J Diabetes Res. 2017;2017:3918681. doi: 10.1155/2017/3918681. Epub 2017 Jan 15.
3
Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.尿血红素加氧酶-1作为早期糖尿病肾病的潜在生物标志物。
Nephrology (Carlton). 2017 Jan;22(1):58-64. doi: 10.1111/nep.12719.
4
Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.2型糖尿病患者血清β-促胰岛素分泌素水平升高与尿白蛋白排泄及肾功能相关。
Cardiovasc Diabetol. 2016 Jan 7;15:3. doi: 10.1186/s12933-015-0326-9.
5
The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.2型糖尿病不同尿白蛋白阶段患者血清sKlotho和NGAL水平变化及其相关性
Diabetes Res Clin Pract. 2014 Nov;106(2):343-50. doi: 10.1016/j.diabres.2014.08.026. Epub 2014 Sep 16.
6
Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.2型糖尿病患者尿单核细胞趋化蛋白-1的临床意义及不同水平
Diabetes Res Clin Pract. 2009 Feb;83(2):215-9. doi: 10.1016/j.diabres.2008.09.048. Epub 2008 Dec 20.
7
Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.二肽基肽酶-4抑制在慢性肾脏病中的作用及预防糖尿病相关肾损伤的潜力
Nutr Metab Cardiovasc Dis. 2016 May;26(5):361-73. doi: 10.1016/j.numecd.2016.01.001. Epub 2016 Jan 13.
8
Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.鉴定尿可溶性E-钙黏蛋白作为糖尿病肾病的一种新型生物标志物。
Diabetes Metab Res Rev. 2009 Mar;25(3):232-41. doi: 10.1002/dmrr.940.
9
Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.氨基肽酶N、N-乙酰-β-D-葡萄糖苷酶和二肽基肽酶IV在评估肾小球病患者肾小管功能障碍中的诊断价值。
Ren Fail. 2008;30(9):896-903. doi: 10.1080/08860220802359048.
10
[Change and significance of urinary smad3 in type 2 diabetic nephropathy].2型糖尿病肾病患者尿Smad3的变化及意义
Zhonghua Yi Xue Za Zhi. 2013 Apr 9;93(14):1067-71.

引用本文的文献

1
Association of urinary dipeptidyl peptidase 4 activity with clinical outcomes in people with chronic kidney disease.慢性肾脏病患者尿二肽基肽酶4活性与临床结局的关联
Sci Rep. 2025 Jul 2;15(1):23190. doi: 10.1038/s41598-025-06395-x.
2
The role of exosomes in the pathogenesis and management of diabetic kidney disease: a systematic review and meta-analysis.外泌体在糖尿病肾病发病机制及治疗中的作用:一项系统综述和荟萃分析
Front Endocrinol (Lausanne). 2024 Dec 3;15:1398382. doi: 10.3389/fendo.2024.1398382. eCollection 2024.
3
Incretin-based therapy: a new horizon in diabetes management.
基于肠促胰岛素的疗法:糖尿病管理的新视野。
J Diabetes Metab Disord. 2024 Aug 17;23(2):1665-1686. doi: 10.1007/s40200-024-01479-3. eCollection 2024 Dec.
4
Exploring senescence as a modifier of β cell extracellular vesicles in type 1 diabetes.探讨衰老作为 1 型糖尿病β细胞细胞外囊泡的修饰物。
Front Endocrinol (Lausanne). 2024 Aug 22;15:1422279. doi: 10.3389/fendo.2024.1422279. eCollection 2024.
5
Liquid Biopsy: A Game Changer for Type 2 Diabetes.液体活检:2 型糖尿病的变革者。
Int J Mol Sci. 2024 Feb 25;25(5):2661. doi: 10.3390/ijms25052661.
6
Association of DPP-4 Concentrations with the Occurrence of Gestational Diabetes Mellitus and Excessive Gestational Weight Gain.DPP-4 浓度与妊娠期糖尿病和妊娠体重过度增加的发生的关系。
Int J Mol Sci. 2024 Feb 2;25(3):1829. doi: 10.3390/ijms25031829.
7
Surfaceome analysis of extracellular vesicles from senescent cells uncovers uptake repressor DPP4.衰老细胞来源的细胞外囊泡的表面组分析揭示了摄取抑制剂 DPP4。
Proc Natl Acad Sci U S A. 2023 Oct 24;120(43):e2219801120. doi: 10.1073/pnas.2219801120. Epub 2023 Oct 20.
8
Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications.外泌体作为2型糖尿病及其相关并发症的生物标志物和治疗手段
Front Physiol. 2023 Sep 8;14:1241096. doi: 10.3389/fphys.2023.1241096. eCollection 2023.
9
Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.基于非依赖性采集蛋白质组学的用于诊断糖尿病肾病的尿液外泌体无创生物标志物的鉴定。
Int J Mol Sci. 2023 Sep 1;24(17):13560. doi: 10.3390/ijms241713560.
10
Recent Advances of Proteomics in Management of Acute Kidney Injury.蛋白质组学在急性肾损伤管理中的最新进展
Diagnostics (Basel). 2023 Aug 11;13(16):2648. doi: 10.3390/diagnostics13162648.